Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Emotional Link LLC CEO Naoto Sato Interviews Associate Professor Mai Uchida, Harvard Medical School, on "How to deal with Blowing up on SNS" 2023-09-27 22:00
OBiO has launched its state-of-the-art GMP production facility Intelli-M to expedite innovative and advanced therapies to patients who are in need. 2023-09-27 21:00
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference 2023-09-27 08:30
ABM Therapeutics' ABM-1310 Granted Fast Track Designation by the FDA Following Orphan Drug Designation 2023-09-27 00:00
China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering 2023-09-26 21:00
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update 2023-09-26 20:51
WuXi Vaccines Launches Its First Vaccines CDMO Site in China 2023-09-26 15:41
Chime Biologics Enters into a Strategic Cooperation Agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch 2023-09-25 20:15
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients 2023-09-25 20:00
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology 2023-09-25 19:00
Xtep Unveils Milestone Brand Strategy Upgrade to Offer World-Class Running Shoes and Gears 2023-09-25 18:48
MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment 2023-09-23 18:29
Concord Medical Reports Financial Results for the First Half of 2023 2023-09-23 05:00
Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development 2023-09-22 20:15
MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil 2023-09-22 16:41
FDA Grants Fast Track Designation to 9MW3011 2023-09-22 08:00
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function 2023-09-21 21:00
Golidocitinib Granted Priority Review by China NMPA for the Treatment of r/r PTCL 2023-09-21 20:26
VEDU Announces New Business Development and Management Team Changes 2023-09-21 20:00
AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT 2023-09-21 19:30
1 62 63 64 65 66 801